![Ralph Niven](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ralph Niven
Direttore Tecnico/Scientifico/R&S presso AEROVATE THERAPEUTICS, INC.
Patrimonio netto: 28 077 $ in data 31/05/2024
Profilo
Ralph Niven is currently the Chief Scientific Officer at Aerovate Therapeutics, Inc. Prior to his current position, he held various roles including Principal at Amgen, Inc., Senior Vice President-Preclinical Development at Windtree Therapeutics, Inc. from 2001 to 2005, Chief Technology Officer at APT Pharmaceuticals, Inc. from 2007 to 2012, and Principal at Advanced Inhalation Research, Inc. He also worked as a Principal at Novartis Pharmaceuticals Corp.
from 2012 to 2017 and at Megabios Corp.
Dr. Niven holds an MBA from George Washington University, a doctorate from the University of Kentucky, and an undergraduate degree from the University of Strathclyde.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
05/02/2024 | 1 609 ( 0.01% ) | 28 077 $ | 31/05/2024 |
Posizioni attive di Ralph Niven
Società | Posizione | Inizio |
---|---|---|
AEROVATE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Ralph Niven
Società | Posizione | Fine |
---|---|---|
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/01/2017 |
APT Pharmaceuticals, Inc.
![]() APT Pharmaceuticals, Inc. BiotechnologyHealth Technology APT Pharmaceuticals, Inc. operated as a drug development company. The company was founded on December 15, 1999 and was headquartered in Burlingame, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2012 |
WINDTREE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2005 |
Advanced Inhalation Research, Inc.
![]() Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Advanced Inhalation Research, Inc. is a company that develops dry-powder drug delivery systems for respiratory patients. The company is based in Cambridge, MA. The company was founded by Terrance G. McGuire, Justin S. Hanes. Advanced Inhalation Research was acquired by Alkermes, Inc., part of Alkermes Plc from September 16, 2011 on February 01, 1999 for $114.54 million. | Corporate Officer/Principal | - |
Megabios Corp. | Corporate Officer/Principal | - |
Formazione di Ralph Niven
George Washington University | Masters Business Admin |
University of Kentucky | Doctorate Degree |
University of Strathclyde | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
AMGEN INC. | Health Technology |
WINDTREE THERAPEUTICS, INC. | Health Technology |
AEROVATE THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
APT Pharmaceuticals, Inc.
![]() APT Pharmaceuticals, Inc. BiotechnologyHealth Technology APT Pharmaceuticals, Inc. operated as a drug development company. The company was founded on December 15, 1999 and was headquartered in Burlingame, CA. | Health Technology |
Advanced Inhalation Research, Inc.
![]() Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Advanced Inhalation Research, Inc. is a company that develops dry-powder drug delivery systems for respiratory patients. The company is based in Cambridge, MA. The company was founded by Terrance G. McGuire, Justin S. Hanes. Advanced Inhalation Research was acquired by Alkermes, Inc., part of Alkermes Plc from September 16, 2011 on February 01, 1999 for $114.54 million. | Health Technology |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Megabios Corp. | Health Technology |
- Borsa valori
- Insiders
- Ralph Niven